NeuroDerm Parkinson’s Drug Inches Closer To Market With Phase III Win

 
• By Alaric DeArment
  
Mitsubishi Tanabe Pharma subsidiary NeuroDerm announced positive Phase III results from its Parkinson's drug trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D